Omicron News and Research

RSS
The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

31 Mar 2022
Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

31 Mar 2022
Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

31 Mar 2022
Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

31 Mar 2022
KHN’s ‘What the Health?’: Funding for the next pandemic

KHN’s ‘What the Health?’: Funding for the next pandemic

31 Mar 2022
NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

31 Mar 2022
Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

31 Mar 2022
‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

31 Mar 2022
Booster doses provide strong protection against hospitalization and death from COVID-19

Booster doses provide strong protection against hospitalization and death from COVID-19

30 Mar 2022
Inconsistency in disease severity across SARS-CoV-2 variants

Inconsistency in disease severity across SARS-CoV-2 variants

30 Mar 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

30 Mar 2022
Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

30 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

30 Mar 2022
Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

29 Mar 2022
Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

29 Mar 2022
A bioinformatics approach for detecting SARS-CoV-2 co-infections

A bioinformatics approach for detecting SARS-CoV-2 co-infections

29 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback